Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology
Market Cap
$382.13 Million
CN¥2.80 Billion CNY
Market Cap Rank
#15636 Global
#4167 in China
Share Price
CN¥14.78
Change (1 day)
-1.79%
52-Week Range
CN¥13.52 - CN¥26.60
All Time High
CN¥50.68
About

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a me… Read more

Shandong Sito Bio-technology Co Ltd - Asset Resilience Ratio

Latest as of September 2020: 0.35%

Shandong Sito Bio-technology Co Ltd (300583) has an Asset Resilience Ratio of 0.35% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥10.00 Million
Cash + Short-term Investments
Total Assets
CN¥2.87 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2017–2019)

This chart shows how Shandong Sito Bio-technology Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shandong Sito Bio-technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥10.00 Million 0.35%
Total Liquid Assets CN¥10.00 Million 0.35%

Asset Resilience Insights

  • Limited Liquidity: Shandong Sito Bio-technology Co Ltd maintains only 0.35% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shandong Sito Bio-technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Sito Bio-technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Shandong Sito Bio-technology Co Ltd (2017–2019)

The table below shows the annual Asset Resilience Ratio data for Shandong Sito Bio-technology Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2019-12-31 6.81% CN¥203.36 Million CN¥2.99 Billion -14.84pp
2018-12-31 21.64% CN¥561.57 Million CN¥2.59 Billion -5.96pp
2017-12-31 27.61% CN¥558.88 Million CN¥2.02 Billion --
pp = percentage points